U.S. Chondroitin Sulfate Market Size & Outlook, 2026-2033
The chondroitin sulfate market in the United States is expected to reach a projected revenue of US$ 459.0 million by 2033. A compound annual growth rate of 3.7% is expected of the United States chondroitin sulfate market from 2026 to 2033.
The U.S. chondroitin sulfate market generated a revenue of USD 344.3 million in 2025 and is expected to reach USD 459.0 million by 2033.
The U.S. market is expected to grow at a CAGR of 3.7% from 2026 to 2033.
In terms of segment, bovine was the largest revenue generating source in 2025.
Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
Chondroitin sulfate market data book summary
Market revenue in 2025
USD 344.3 million
Market revenue in 2033
USD 459.0 million
Growth rate
3.7% (CAGR from 2026 to 2033)
Largest segment
Bovine
Fastest growing segment
Synthetic
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Poultry, Bovine, Shark, Swine, Synthetic
Key market players worldwide
Merck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts
Other key industry trends
In terms of revenue, U.S. accounted for 27.4% of the global chondroitin sulfate market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. chondroitin sulfate market is projected to lead the regional market in terms of revenue in 2033.
U.S. is the fastest growing regional market in North America and is projected to reach USD 459.0 million by 2033.
The prevalence of osteoarthritis is growing rapidly in the U.S. chondroitin sulfate sourced from bovine is preferred in the country for the treatment of osteoarthritis, HIV, heart diseases, and cholesterol.
Chondroitin sulfate is regulated by the U.S. Food and Drug Administration, thus, can be used in food products and dietary supplements. The U.S. imports high amount of chondroitin sulfate from China.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Chondroitin Sulfate Market Outlook will help companies and investors design strategic landscapes.
Bovine was the largest segment with a revenue share of 38.92% in 2025.
Horizon Databook has segmented the U.S. chondroitin sulfate market based on poultry, bovine, shark, swine, synthetic covering the revenue growth of each sub-segment from 2021 to 2033.
The prevalence of osteoarthritis is growing rapidly in the U.S. chondroitin sulfate sourced from bovine is preferred in the country for the treatment of osteoarthritis, HIV, heart diseases, and cholesterol.
Chondroitin sulfate is regulated by the U.S. Food and Drug Administration, thus, can be used in food products and dietary supplements. The U.S. imports high amount of chondroitin sulfate from China.
U.S. Chondroitin Sulfate Market Source Outlook (Revenue, USD Million , 2021-2033)
Bovine
Swine
Poultry
Shark
Synthetic
U.S. Chondroitin Sulfate Market Application Outlook (Revenue, USD Million , 2021-2033)
Nutraceuticals
Pharmaceuticals
Animal Feed
Personal Care & Cosmetics
Others
Reasons to subscribe to Chondroitin Sulfate Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Chondroitin Sulfate Market Outlook databook
Our clientele includes a mix of Chondroitin Sulfate Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Chondroitin Sulfate Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Chondroitin Sulfate Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.